Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | +2.64% |
|
+8.36% | +105.88% |
Jun. 24 | Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index | CI |
Jun. 12 | Connect Biopharma Names New Chief Executive, Chair | MT |
Financials (USD)
Sales 2024 * | 148M | Sales 2025 * | 178M | Capitalization | 527M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 1M | EV / Sales 2024 * | 3.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.96 x |
P/E ratio 2024 * |
-38.9
x | P/E ratio 2025 * |
525
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on Heron Therapeutics, Inc.
1 day | +2.64% | ||
1 week | +8.36% | ||
Current month | -5.41% | ||
1 month | +2.64% | ||
3 months | +26.35% | ||
6 months | +101.15% | ||
Current year | +105.88% |
![Extreme 3.01](/images/extremecours_fleche.png)
![Extreme 3.01](/images/extremecours_fleche.png)
![Extreme 1.66](/images/extremecours_fleche.png)
![Extreme 0.5](/images/extremecours_fleche.png)
![Extreme 0.5](/images/extremecours_fleche.png)
![Extreme 0.5](/images/extremecours_fleche.png)
![Extreme 0.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-28 | 3.5 | +2.64% | 8,612,107 |
24-06-27 | 3.41 | +2.40% | 1,159,273 |
24-06-26 | 3.33 | +9.18% | 1,610,241 |
24-06-25 | 3.05 | -4.09% | 1,296,474 |
24-06-24 | 3.18 | -1.55% | 1,418,575 |
Delayed Quote Nasdaq, June 28, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+105.88% | 527M | |
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- HRTX Stock